Met XL 3D 25/6.25 Tablet ER
Marketer
Ajanta Pharma Ltd
Salt Composition
Chlorthalidone (6.25mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg)
Overview Met XL 3D 25/6.25 Tablet ER
Amlodipine/Hydrochlorothiazide Extended-Release Tablets 25mg/6.25mg (Met XL 3D equivalent) are used to manage hypertension. This dual-action medication lowers blood pressure by promoting blood vessel dilation and improving cardiac output. It also reduces excess fluid and electrolytes. This medication can be administered with or without food, but consistent daily timing optimizes efficacy. Its diuretic effect may increase urination; therefore, daytime administration or at least four hours before sleep is recommended. Dosage and frequency are determined by your physician based on individual needs and response. Continuous use, as directed, is crucial for sustained blood pressure control. Common side effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular monitoring of renal function and electrolyte levels is essential. Optimal results are achieved in conjunction with lifestyle modifications such as a balanced diet, regular physical activity, and smoking cessation. Increased fluid intake is advised to counteract potential dehydration. Prior to commencing treatment, inform your physician of any pregnancy, circulatory disorders, liver or kidney impairment, and all other medications you are currently using, as interactions may affect efficacy or drug action.
Uses of Met XL 3D 25/6.25 Tablet ER
Elevated blood pressure
Major Benefits of Met XL 3D 25/6.25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Met XL 3D 25/6.25 Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Met XL 3D 25/6.25 Tablet ER:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Weakness
- Cold extremities
- Numbness of extremity
- Increased uric acid level in blood
- Increased blood lipid level
- Decreased magnesium level in blood
- Slow heart rate
- Decreased sodium level in blood
- Decreased blood pressure
How to use Met XL 3D 25/6.25 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Met XL 3D 25/6.25 Extended-Release tablets may be consumed with or without food, although consistent daily timing is recommended.
How Met XL 3D 25/6.25 Tablet ER works:
Each Met XL 3D 25/6.25 extended-release tablet contains chlorthalidone, metoprolol succinate, and telmisartan, a triple drug combination for effective blood pressure management.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Met XL 3D 25/6.25 Tablet ER poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
Extended-release Met XL 3D 25/6.25 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential advantages outweigh the known hazards. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Met XL 3D 25/6.25mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Met XL 3D 25/6.25 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Met XL 3D 25/6.25 Tablet ER, potentially requiring a modified dosage. Physician consultation is advised; this medication is generally unsuitable for such patients.
LiverCAUTION
Individuals with liver impairment should use Met XL 3D 25/6.25 Extended-Release tablets cautiously, as dose modification may be necessary. Consult a physician for guidance. The use of Met XL 3D 25/6.25 Extended-Release tablets is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Met XL 3D 25/6.25 Tablet ER :
Should you forget a Met XL 3D 25/6.25 Tablet ER dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Met XL 3D 25/6.25 Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | HEART |



